Pricing Log in Create free account

Curanex Pharmaceuticals Inc (CURX) vs Moleculin Biotech, Inc. (MBRX)

Curanex Pharmaceuticals Inc and Moleculin Biotech, Inc. are both Biotechnology companies. Curanex Pharmaceuticals Inc and Moleculin Biotech, Inc. are of similar size ($7.6M and $7.6M). Curanex Pharmaceuticals Inc has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 9 metrics below, Moleculin Biotech, Inc. leads on 5 and Curanex Pharmaceuticals Inc on 4.

Valuation

Metric CURX MBRX Biotechnology median
P/E n/m 0.03 8.50
P/S n/m n/m 9.71
P/B 1.37 0.14 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.19 0.64
EV/Sales n/m n/m 9.21
Earnings yield (168.83%) 4,008.00% (33.15%)
Free cash flow yield (184.34%) (1,600.09%) (25.50%)

Profitability

Metric CURX MBRX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (411.10%) (1,471.05%) (56.36%)
Return on assets (357.22%) (152.41%) (48.04%)
Return on invested capital (356.67%) (417.27%) 0.00%

Growth

Metric CURX MBRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (466.67%) 82.01% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CURX MBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.95 0.94 4.72
Net debt to EBITDA 1.20 0.35 0.96

Dividend

Metric CURX MBRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CURX MBRX Biotechnology median
Market cap 7.58m 7.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack